BLOOD-BASED BIOMARKERS FOR PREDICTING POST-STROKE PROGNOSIS: A SCOPING REVIEW OF PENTRAXIN-3, NEUROPENTRAXIN-1, AND NEUROPENTRAXIN-2. magna-neurologica. 2026;4(2):175-186. doi:10.20961/magnaneurologica.v4i2.3308